Multidrug resistance reversal activity of key ningalin analogues
- 12 April 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (10) , 1777-1781
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Pharmacophore Model of Drugs Involved in P-Glycoprotein Multidrug Resistance: Explanation of Structural Variety (Hypothesis)Journal of Medicinal Chemistry, 2002
- Three-Dimensional Quantitative Structure-Activity Relationships of Inhibitors of P-GlycoproteinMolecular Pharmacology, 2002
- Structure-Activity Relationships of Multidrug Resistance ReversersCurrent Medicinal Chemistry, 2001
- Total Synthesis of Ningalin B Utilizing a Heterocyclic Azadiene Diels−Alder Reaction and Discovery of a New Class of Potent Multidrug Resistant (MDR) Reversal AgentsThe Journal of Organic Chemistry, 2000
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- Total Syntheses of Ningalin A, Lamellarin O, Lukianol A, and Permethyl Storniamide A Utilizing Heterocyclic Azadiene Diels−Alder ReactionsJournal of the American Chemical Society, 1998
- Ningalins A−D: Novel Aromatic Alkaloids from a Western Australian Ascidian of the Genus DidemnumThe Journal of Organic Chemistry, 1997
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Structural characteristics of compounds that modulate P-glycoprotein-associated multidrug resistanceAdvances in Enzyme Regulation, 1990
- Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance.Proceedings of the National Academy of Sciences, 1989